MESSAGE
| DATE | 2006-10-18 |
| FROM | Ruben Safir
|
| SUBJECT | Subject: [NYLXS - HANGOUT] Re: Important Information on BIAXIN XL
|
From owner-hangout-at-mrbrklyn.com Thu Oct 19 00:52:16 2006
Received: from www2.mrbrklyn.com (localhost [127.0.0.1])
by www2.mrbrklyn.com (8.13.1/8.13.1/SuSE Linux 0.7) with ESMTP id k9J4qEUB029870
for ; Thu, 19 Oct 2006 00:52:16 -0400
Received: (from majordomo-at-localhost)
by www2.mrbrklyn.com (8.13.1/8.13.1/Submit) id k9J4qEx2029869
for hangout-outgoings; Thu, 19 Oct 2006 00:52:14 -0400
X-Authentication-Warning: www2.mrbrklyn.com: majordomo set sender to owner-hangout-at-nylxs.com using -f
Received: from flatbush.mrbrklyn.com (flatbush.mrbrklyn.com [10.0.0.62])
by www2.mrbrklyn.com (8.13.1/8.13.1/SuSE Linux 0.7) with ESMTP id k9J4q6Fg029865;
Thu, 19 Oct 2006 00:52:08 -0400
Subject: [NYLXS - HANGOUT] Re: Important Information on BIAXIN XL
From: Ruben Safir
To: RXInsider
In-Reply-To: <200610181557.k9IFvjjK043476-at-rxinsider1.rawdata.net>
References: <200610181557.k9IFvjjK043476-at-rxinsider1.rawdata.net>
Content-Type: text/plain; charset=utf-8
Date: Thu, 19 Oct 2006 00:55:03 -0400
Message-Id: <1161233703.22111.1.camel-at-flatbush.mrbrklyn.com>
Mime-Version: 1.0
X-Mailer: Evolution 2.2.1
Content-Transfer-Encoding: 8bit
Sender: owner-hangout-at-mrbrklyn.com
Precedence: bulk
X-Keywords:
X-UID: 17165
Status: RO
Content-Length: 4084
Lines: 93
Fuck Abbott
On Wed, 2006-10-18 at 11:57 -0400, RXInsider wrote:
> Pharmacy Product
>
> Abbott Laboratories
> 200 Abbott Park
> Abbott Park, IL 60064
>
>
>
>
>
>
> August 30, 2006
>
> Dear
> Wholesaler/Retailer/Pharmacist:
>
> This letter is to clarify recent
> events regarding the availability
> of a generic version of
> BIAXIN® XL (clarithromycin
> extended-release).
>
> Abbott and Teva reached an
> agreement settling our outstanding
> litigation regarding BIAXIN® XL.
> Per that agreement, although Teva
> did ship a limited supply of
> generic clarithromycin
> extended-release, Teva will not
> sell any additional product at this
> time. Even though the court had
> ordered Teva to pull its product
> from the market, Abbott agreed to
> allow the Teva product that had
> already shipped to remain in the
> market
> and be distributed.
>
> With cold and flu season just
> around the corner, incidence of
> respiratory tract infections will
> soon be on the rise. BIAXIN® XL
> will continue to be available
> exclusively from Abbott. You can
> rely on Abbott to be your single
> source of clarithromycin
> extended-release and to supply you
> with BIAXIN® XL.
>
> Best regards,
>
> Abbott Laboratories
>
>
>
>
> ©2006 Abbott
> Laboratories
> Abbott Park, IL
> 60064
> 06H-010-Q525-1
> August 2006
>
>
>
> www.BiaxinXL.com
>
>
>
>
>
>
>
>
>
>
>
>
> RXinsider.com
> RXinsider LTD - 1300
> Division Rd, Suite 205,
> West Warwick, RI 02893
>
> Tracking
>
>
> Advertising Information (direct email broadcasts).
> Please remove my email from your list.
>
>
|
|
